Barry Mangum, PharmD
Founder and CEO
As Founder and CEO, Dr. Mangum is responsible for vision. But, it’s bigger than just a corporate initiative. It’s a vision of profound and meaningful change in global pediatric clinical research. That’s what Paidion is all about, being a catalyst for change in an old paradigm and laying the groundwork for important new development programs of safe and effective medicines for children.
Responsible for partnering with clients to implement clinical trials for all phases of pediatric drug development, Dr. Mangum brings decades of pediatric clinical research expertise to Paidion. His extensive academic experience includes serving as faculty and researcher in pediatrics and clinical pharmacology/pharmacotherapy at Duke’s and UNC’s medical schools. His corporate experience includes serving as Director of Neonatal/Pediatric Pharmacotherapy for Wake AHEC (Area Health Education Center) and Senior Director of Pediatric Clinical Development Services at Quintiles.
Dr. Mangum He has numerous publications, presentations and memberships, including co-authorship of NeoFax: A Manual of Drugs Used in Neonatal Care, the leading guide for dosing neonatal medications in the US, as well as the NeoFax software package and mobile device app. He is currently working on several large pediatric research projects. For his full CV, please click here.